Comparative statistics by cancer site (ICD-10)

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	5184	5094	98.3	90	1.7	0.3	0.6	0.5	0.3	98.6	73.5
	Costa Rica	1995-2000	2462	1866	75.8	596	24.2	7.1	4.5	5.8	6.8	82.6	45.3
	Cuba	1994-1995	2169	2104	97.0	65	3.0	0.9	0.3	1.4	0.4	97.4	54.5
	Gambia	1993-1997	61	56	91.8	5	8.2	8.2	1.5	0.0	0.0	91.8	4.6
	India - Barshi	1993-2000	124	119	96.0	5	4.0	0.0	0.0	3.2	0.8	96.8	41.4
	India - Chennai	1990-1999	3067	2351	76.7	716	23.3	12.4	2.9	2.0	6.0	82.6	26.9
	India - Karunagappally	1991-1997	190	188	98.9	2	1.1	0.5	0.0	0.0	0.5	99.5	36.1
	India - Mumbai	1992-1994	7294	5460	74.9	1834	25.1	12.2	0.3	0.3	12.3	87.2	30.9
	Philippines - Manila	1994-1995	415	322	77.6	93	22.4	14.2	6.3	1.2	0.7	78.3	33.1
	Philippines - Rizal	1996-1997	1299	341	26.3	958	73.7	52.9	12.4	5.2	3.2	29.5	5.7
	Saudi Arabia - Riyadh	1994-1996	298	233	78.2	65	21.8	12.7	4.4	3.0	1.7	79.9	57.4
	Thailand - Chiang Mai	1993-1997	544	354	65.1	190	34.9	7.1	12.5	8.5	6.8	71.9	39.0
	Thailand - Khon Kaen	1993-1997	418	173	41.4	245	58.6	24.4	22.2	7.7	4.3	45.7	21.5
	Thailand - Lampang	1990-2000	830	821	98.9	9	1.1	0.0	0.0	1.0	0.1	99.0	59.0
	Thailand - Songkhla	1990-1999	562	288	51.2	274	48.8	12.1	9.8	11.0	15.8	67.1	40.4
	Turkey - Izmir	1995-1997	1329	806	60.7	523	39.3	10.9	2.3	1.8	24.3	85.0	72.0
	Uganda - Kampala	1993-1997	162	96	59.3	66	40.7	27.8	9.3	1.9	1.9	61.1	10.9
	Zimbabwe - Harare	1993-1997	258	250	96.9	8	3.1	2.7	0.4	0.0	0.0	96.9	39.3

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period